Zenas BioPharma, Inc. Operating Lease Right-of-Use Assets
Zenas BioPharma, Inc. (ZBIO) had Operating Lease Right-of-Use Assets of $821.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $821.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.09M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.35M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $807.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $821.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.09M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.35M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $807.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.01M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.20M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.00M 10-K · filed 2026-03-16 |
| 2024-09-30 | $399.00K 10-Q · filed 2024-11-12 |
| 2023-12-31 | $821.00K 10-K · filed 2025-03-11 |